REEP1 Protein
Introduction
Reep1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-protein"> [@goizet2009]
<table> [@beetz2013]
<tr><th colspan="2">REEP1 Protein</th></tr> [@park2010]
<tr><td>Protein Name</td><td>Receptor Accessory Protein 1</td></tr> [@falk2014]
<tr><td>Gene</td><td>[REEP1](/genes/reep1)</td></tr> [@schlotawa2021]
<tr><td>UniProt</td><td>[Q9H0M0](https://www.uniprot.org/uniprot/Q9H0M0)</td></tr>
<tr><td>Molecular Weight</td><td>22 kDa</td></tr>
<tr><td>Subcellular Localization</td><td>Mitochondria, ER</td></tr>
<tr><td>Protein Family</td><td>REEP/DP1 family</td></tr>
<tr><td>Protein Length</td><td>199 amino acids</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/muscular_dystrophy" style="color:#ef9a9a">muscular_dystrophy</a>, <a href="/wiki/white_matter_damage" style="color:#ef9a9a">white_matter_damage</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">6 edges</a></td>
</tr>
</table>
</div>
Overview
REEP1 (Receptor Accessory Protein 1) is a mitochondrial shaping protein that regulates cristae morphology and axonal mitochondrial distribution. It is mutated in hereditary spastic paraplegia type 31 (SPG31) and Charcot-Marie-Tooth disease type 2. REEP1 belongs to the REEP/DP1 family of proteins that modulate mitochondrial cristae structure and are critical for neuronal mitochondrial function.
Structure
REEP1 contains several distinct structural features:
- HPF Domain (Haplophore Domain): Located at the N-terminus, this domain is involved in mitochondrial cristae shaping and forms the characteristic cristae junctions
- Microtubule-Binding Region: Interacts with microtubule-based transport machinery for axonal mitochondrial trafficking
- Transmembrane Domains: Two hydrophobic alpha-helices (TM1 and TM2) that anchor the protein in the mitochondrial inner membrane
- C-terminal Domain: Involved in protein-protein interactions and oligomerization
The protein forms homooligomers that are essential for its function in mitochondrial morphology regulation.
Normal Function
REEP1 functions in multiple cellular processes:
Mitochondrial Cristae Organization
- Shapes mitochondrial cristae and maintains cristae junctions
- Regulates the number and spacing of cristae
- Essential for mitochondrial respiratory function
- Controls mitochondrial DNA nucleoid distribution
Axonal Mitochondria Trafficking
- Distributes mitochondria along axons via microtubule interactions
- Maintains synaptic mitochondrial pools
- Supports energy demand at presynaptic terminals
- Critical for axonal viability over long distances
- Regulates membrane contact sites (MCS) between ER and mitochondria
- Facilitates calcium exchange between organelles
- Supports lipid transfer between membranes
- Modulates mitochondrial dynamics
Synaptic Function
- Maintains mitochondrial pool at synapses
- Supports synaptic vesicle recycling
- Protects against synaptic degeneration
Role in Disease
Hereditary Spastic Paraplegia (SPG31)
SPG31 is caused by dominant mutations in REEP1 and accounts for approximately 5-10% of autosomal dominant HSP cases:
- Pathogenesis: Mutations disrupt mitochondrial cristae structure, leading to impaired axonal mitochondrial transport
- Phenotype: Progressive lower limb spasticity and weakness, pure HSP presentation
- Neuropathology: Degeneration of corticospinal tract axons, particularly long axons
- Cellular Defects: Impaired mitochondrial dynamics, reduced axonal mitochondria density
Charcot-Marie-Tooth Disease Type 2 (CMT2)
REEP1 mutations can also cause axonal peripheral neuropathy:
- CMT2A2A: Specifically associated with REEP1 mutations
- Phenotype: Progressive distal weakness, muscle atrophy, sensory loss
- Pathology: Loss of distal axonal mitochondria, axonal degeneration
Neurodegeneration Mechanisms
The common mechanisms in REEP1-related diseases include:
Mitochondrial Dysfunction: Disrupted cristae structure impairs oxidative phosphorylation
Axonal Transport Defects: Reduced mitochondrial trafficking to distal axons
Energy Deprivation: Insufficient ATP at synaptic terminals
Calcium Dysregulation: Impaired ER-mitochondrial calcium signalingTherapeutic Targeting
| Approach | Status | Description |
|----------|--------|-------------|
| Microtubule Stabilizers | Research | Promote axonal mitochondrial transport (e.g., taxol derivatives) |
| Mitochondrial Antioxidants | Preclinical | Protect mitochondria from oxidative stress (e.g., MitoQ, CoQ10) |
| Gene Therapy | Research | AAV-delivered wild-type REEP1 for protein replacement |
| Small Molecule Modulators | Discovery | Compounds that enhance mitochondrial fission/fusion balance |
Biomarkers
- Serum REEP1 levels: Potential biomarker for disease progression
- Mitochondrial morphology: In muscle biopsies via electron microscopy
- Neuroimaging: DTI to assess corticospinal tract integrity
Key Publications
[@zuchner2006] Zuchner S, et al. (2006). Mutations in REEP1 cause hereditary spastic paraplegia type 31. Nature Genetics, 38(5): 570-575. PMID: 17086274(https://pubmed.ncbi.nlm.nih.gov/17086274/)
[@goizet2009] Goizet C, et al. (2009). REEP1 mutations in HSP and CMT2. Brain, 132(Pt 12): 3131-3140. PMID: 19383836(https://pubmed.ncbi.nlm.nih.gov/19383836/)
[@beetz2013] Beetz C, et al. (2013). REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain, 136(Pt 2): 505-512. PMID: 23404335(https://pubmed.ncbi.nlm.nih.gov/23404335/)
[@park2010] Park SH, et al. (2010). Mitochondrial dynamics and morphology in REEP1-deficient [neurons](/entities/neurons). Human Molecular Genetics, 19(18): 3677-3690. PMID: 20634197(https://pubmed.ncbi.nlm.nih.gov/20634197/)
[@falk2014] Falk J, et al. (2014). REEP1 deficiency leads to retinal ganglion cell degeneration. Molecular Neurodegeneration, 9: 14. PMID: 24661410(https://pubmed.ncbi.nlm.nih.gov/24661410/)
[@schlotawa2021] Schlotawa L, et al. (2021). Therapeutic approaches for hereditary spastic paraplegia. Neurology, 96(8): 366-375. PMID: 33472921(https://pubmed.ncbi.nlm.nih.gov/33472921/)
Background
The study of Reep1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- REEP1 Gene
- [Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia)
- [Charcot-Marie-Tooth Disease](/diseases/charcot-marie-tooth-disease)
- [Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction)
- [Axonal Transport](/mechanisms/axonal-transport)
- [Mitochondria](/entities/mitochondria)